Company intelligence / Profile preview

H&T Presspart

Blackburn, Lancashire, United Kingdompresspart.com ↗

Ownership: Private
Employees: ~417
Development stage: Commercial

Overview

H&T Presspart does not develop its own therapeutics but manufactures commercial-stage drug delivery devices and components widely used in the pharmaceutical industry. Its products are integral to many marketed respiratory therapies.

Therapeutic areas: Pulmonology
Modalities: Device (including metered-dose inhalers and dry powder inhalers)Small molecule (as components are used for small molecule drug delivery)Nanoparticle (for certain device applications)Biologic (as devices may be used for biologic formulations)
Industry: Therapeutic Medical Devices

Partnerships

Partners with leading global pharmaceutical companies in the respiratory space; specific names not disclosed but includes major MDI manufacturers.

Beyond the preview

Go deeper on H&T Presspart.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on H&T Presspart.

Explore the full profile